Tva is a medical company based in Austin, TX that specializes in providing a non-surgical alternative for creating arteriovenous fistulas (AVF) in patients with chronic kidney disease who require hemodialysis. Their innovative WavelinQ EndoAVF System utilizes an endovascular approach, avoiding the need for open surgery and minimizing scarring and arm disfigurement. With a focus on patient benefits, Tva's system offers multiple anatomical AV fistula locations and various venous procedural approaches, providing more options for end-stage kidney disease patients worldwide.
Tva's WavelinQ EndoAVF System consists of specialized catheters and an electrosurgical unit, which are inserted into the arm's artery and vein to create an endovascular AV fistula. The magnets in the catheters allow for precise alignment, while radiofrequency energy is used to establish a connection between the artery and vein. This innovative procedure offers patients potential benefits compared to traditional surgical creation options, making it a versatile and patient-friendly alternative for vascular access in hemodialysis therapy.
Generated from the website
